NCT05927155View on ClinicalTrials.gov

Effects of Acute Long-acting Bronchodilation on Oxygenation and Peripheral Ventilation in COPD

PHASE3CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

June 15, 2021

Primary Completion Date

March 30, 2022

Study Completion Date

March 30, 2022

Conditions
Pulmonary Disease, Chronic Obstructive
Interventions
DRUG

LABA

Inhalation of 4 puffs of 2,5 µg of a long-acting beta2-agonist (LABA-olodaterol) administered via a spacer device

DRUG

LAMA

Inhalation of 4 puffs of 2,5 µg of a long-acting muscarinic antagonist (LAMA-tiotropium) administered via a spacer device

Trial Locations (1)

1070

Erasme University Hospital, Brussels

All Listed Sponsors
lead

Erasme University Hospital

OTHER